Luyuan Ma
Impact in
-
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- MicroRNA in disease regulation
- Cancer, Lipids, and Metabolism
-
- RNA modifications and cancer
- Circular RNAs in diseases
- Epigenetics and DNA Methylation
Papers in
-
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Cancer, Hypoxia, and Metabolism 2
- Co-authors
- Xiang Zhu (3 shared papers)Xiaofeng Kang (3 shared papers)Nan Huo (3 shared papers)Zhong Chu (3 shared papers)Rui Cong (3 shared papers)Chunyuan Xue (2 shared papers)Nan Du (2 shared papers)Xiaojie Xu (2 shared papers)
- Journals
- Cell Death and Disease (2 papers)Molecular Therapy (1 paper)Molecular Therapy — Oncolytics (1 paper)Medicine (1 paper)Frontiers in Immunology (1 paper)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Luyuan Ma
14 papers receiving 259 citations
Peers
Comparison fields: 5 of 43
- Cancer Research 159
- Molecular Biology 188
- Hepatology 18
- Oncology 50
- Immunology 22
Countries citing papers authored by Luyuan Ma
This map shows the geographic impact of Luyuan Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luyuan Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luyuan Ma more than expected).
Fields of papers citing papers by Luyuan Ma
This network shows the impact of papers produced by Luyuan Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luyuan Ma. The network helps show where Luyuan Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Luyuan Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 88 | |
| 2 | 2021 | 69 | |
| 3 | 2019 | 28 | |
| 4 | 2020 | 21 | |
| 5 | 2020 | 16 | |
| 6 | 2019 | 11 | |
| 7 | 2021 | 9 | |
| 8 | 2020 | 7 | |
| 9 | 2023 | 4 | |
| 10 | 2022 | 4 | |
| 11 | 2025 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2019 | 1 | |
| 15 | 2025 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2024 | 0 |
About Luyuan Ma
Luyuan Ma is a scholar working on Molecular Biology, Cancer Research, Oncology, Hepatology and Epidemiology, having authored 17 papers that have together received 261 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Viral-associated cancers and disorders (2 papers), Epigenetics and DNA Methylation (2 papers), Hepatitis C virus research (2 papers), Liver Disease Diagnosis and Treatment (2 papers), Cancer, Hypoxia, and Metabolism (2 papers) and RNA modifications and cancer (2 papers). The work is most often cited by research in Cancer Research (159 citations), Molecular Biology (188 citations), Hepatology (18 citations), Oncology (50 citations) and Immunology (22 citations). Luyuan Ma has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Xiang Zhu, Xiaofeng Kang, Nan Huo, Zhong Chu, Rui Cong, Chunyuan Xue, Nan Du, Xiaojie Xu, Qihong Li and Jingtong Li. Their work appears in journals such as Cell Death and Disease, Molecular Therapy, Molecular Therapy — Oncolytics, Medicine and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.